6-K

HOLDING(S) IN COMPANY

Company: Indivior Pharmaceuticals, Inc.
Filed: February 25, 2025
Period of Report: February 25, 2025
Accession Number: 0001654954-25-001875

View Document ↗ View on SEC.gov ↗